MVP 0.53% 47.8¢ medical developments international limited

Another Positive Study, page-46

  1. 2,124 Posts.
    lightbulb Created with Sketch. 264
    Faster and non addictive is worth the extra cost, this is no deterrent on cost and the benefits out way the cost decision.

    I can't wait to hear from management in next months Annual report, more the sales outlook without covid lock-downs in France etc.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.